top of page
Search

Novel or not novel? Everything you need to know about the EU Article 4 Novel Food Consultation process

Writer: Atova
Atova
Nov 13
4 min read

Updated: 5 days ago

By Sarah Harrison, Regulatory Scientist at Atova




Is your food ingredient considered a novel food? Determining whether a food or food ingredient is considered novel under EU legislation is not always straightforward. For those food business operators looking to bring new products to the European market, understanding whether an ingredient falls within the scope of the EU Novel Food Regulation is an important early step. Where there is any uncertainty, the Article 4 consultation process provides a formal route to obtain a conclusion from an EU Member State. 


But what does the process involve, when should a company consider submitting a consultation, and what can previous consultations outcomes tell us?


In the latest article from our Atova Regulatory Insights series, Regulatory Scientist Sarah Harrison explores the EU Article 4 consultation process, its advantages and limitations, and the trends emerging from 200 published consultation conclusions.



What is an Article 4 Novel Food consultation?

Under Article 4 of Regulation (EU) 2015/2283, food business operators are responsible for determining whether their products fall within the scope of the Novel Food Regulation. A food is generally considered novel if it was not used for human consumption to a significant degree within the EU before 15 May 1997 and falls within one of the categories set out in Article 3(2)(a).


Where the available evidence does not provide a clear answer, food business operators can submit an Article 4 consultation request to the Member State where they first intend to market their product. The request must include a cover letter, a technical dossier, and supporting evidence, allowing the authority to assess the food’s identity, history of consumption, composition and production process.



What do recent Article 4 consultation outcomes tell us?

At Atova, we monitor published Article 4 consultation conclusions to identify trends in how novel food status is being assessed across the EU. In this article we have analysed 200 published Article 4 consultation conclusions available on the European Commission website up to 30th June 2026. Our findings revealed some interesting trends:


  • 53% resulted in a novel consultation, while 47% were concluded to be non-novel.

  • Plant-derived foods accounted for 49% of all consultations, followed by foods derived from microorganisms, fungi or algae (23.5%)

  • Spain, the Czech Republic and Germany received the highest numbers of consultation requests


The findings also highlighted the importance of demonstrating significant consumption of the specific food or ingredient before 15 May 1997. Evidence that a source plant or microorganism was historically consumed does not automatically establish non-novel status for an extract or isolated ingredient derived from it.


Is an Article 4 consultation the right regulatory strategy? 

An Article 4 consultation can be a valuable tool when there is genuine uncertainty about a food’s novel status. However, it is not necessarily required or appropriate in every situation.


Potential advantages include:

  • Providing a formal route to resolve uncertainty without immediately preparing a full novel food authorisation dossier.

  • Establishing a regulatory conclusion on the specific food assessed

  • There is no EU-Level fee set for the procedure, although applicants should check whether the selected Member State applies a national administrative fee.


There are also important limitations to consider:

  • The conclusion and supporting reasons are published on the European Commission website – this should be considered when managing commercially sensitive information and timing an Article 4 strategy.

  • If the outcome is novel, the food must obtain novel food authorisation before It can be placed on the EU market.

  • The assessment period is four months from dossier validation, with a possible extension of up to a further four months in duly justified cases.



Final thoughts

So, what makes a strong Article 4 consultation? Which ingredients are most likely to receive a novel conclusion, and what can companies learn from previous assessments?


In her full article, Sarah examines the consultation data in greater detail, explores the main reasons behind novel and non-novel conclusions, and shares practical considerations when deciding whether an Article 4 consultation is the right regulatory approach.


If you are uncertain about the novel food status of an ingredient or product, Atova can help. We support companies with novel food status assessments, advice on whether an Article 4 consultation is the appropriate regulatory strategy, and the preparation and submission of consultation requests in accordance with Commission Implementing Regulation (EU) 2018/456.


Contact our team at info@atovaconsulting.com to discuss your regulatory requirements


Read Sarah Harrison’s full article, Novel or Not Novel?- That is the question: Everything you need to know about the EU Article 4 Novel Food Consultation process



About Sarah Harrison

Sarah Harrison is a Regulatory Scientist at Atova, with a background in Animal Science and a master’s degree in Meat Science and Technology. Before joining Atova, Sarah spent over 11 years working as a Study Director and Project Coordinator for a CRO specialising in veterinary medicines, feed additives and parasitology. During this time, she managed multiple projects through to dossier finalisation. Sarah’s interests include sustainable protein and supporting the development of innovative food products. 



Through the Atova Regulatory Insights series, our team shares practical regulatory knowledge and perspectives from across the evolving food-tech landscape, helping companies better understand the regulatory considerations involved in bringing new food products to market.




 
 
 

Comments


bottom of page